<DOC>
	<DOCNO>NCT00646776</DOCNO>
	<brief_summary>The purpose study evaluate exposure rifabutin ( RIB ) administer atazanavir ritonavir ( ATV/RTV )</brief_summary>
	<brief_title>Drug Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Rifabutin</mesh_term>
	<criteria>Healthy male female subject age 18 50 year old body mass index ( BMI ) 18 32 kg/mÂ² Prior enrollment , subject must physical laboratory test finding within normal limit , woman childbearing potential ( WOCBP ) must negative pregnancy test Any significant acute chronic medical illness Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , electrocardiogram ( ECG ) clinical laboratory determination Use prescription drug overthecounter acid controller within 4 week prior study drug administration Use drug , include overthecounter medication herbal preparation within 1 week prior study drug administration</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>